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The mitochondrial outer-
membrane location of the EXD2 
exonuclease contradicts its direct 
role in nuclear DNA repair
Fenna Hensen1, Amandine Moretton2, Selma van Esveld  3, Géraldine Farge2 &  
Johannes N. Spelbrink  1
EXD2 is a recently identified exonuclease that has been implicated in nuclear double-strand break 
repair. Given our long standing interest in mitochondrial DNA maintenance and indications that 
EXD2 could also be a mitochondrial protein we sought to determine its cellular localization and 
possible mitochondrial associated functions. Our results show that EXD2 indeed shows mitochondrial 
localization, but, surprisingly, is found predominantly associated with the mitochondrial outer-
membrane. Gradient purified nuclei show only the faintest hint of EXD2 presence while overexpression 
of the predicted full-length protein shows exclusive mitochondrial localization. Importantly, induction 
of double-strand DNA breaks via X-irradiation or Zeocin treatment does not support the notion that 
EXD2 re-locates to the nucleus following double-strand breaks and thus is unlikely to have a direct 
role in nuclear DNA repair. Knockdown or overexpression of EXD2 affects the cellular distribution of 
mitochondria. These results suggest that the reported defects in nuclear DNA repair following EXD2 
depletion are likely an indirect consequence of altered mitochondrial dynamics and/or function.
Protein function can often be predicted on the basis of signature amino-acid motifs. Exonucleases are no excep-
tion to this rule. However, although a bioinformatics prediction for function in some cases can be unquestionable 
and in vitro activity measurements verify predicted enzymatic activity, if the protein in question is not located 
in the compartment where it is supposed to act, one has to reconsider its function. EXD2 is a newly identified 
exonuclease that has recently been implicated in nuclear double-strand break repair1–3. We have a long standing 
interest in mtDNA maintenance enzymes including nucleases4,5, and as more and more nuclear DNA mainte-
nance proteins have in recent years been assigned a mitochondrial function, we have a keen interest in newly dis-
covered nuclear enzymes. A closer inspection of various available online databases and tools showed that despite 
its recent proposed role in nuclear DNA repair, EXD2 location is predicted to be mitochondrial/cytoplasmic. 
Cellular and mitochondrial localization prediction programs vary in their estimation. For example MitoProt II6 
gives a reasonably high mitochondrial probability score of 69%, PSORT II7 gives a poor mitochondrial prediction 
and TargetP8 suggests the protein is secreted. Several published papers have suggested a mitochondrial function 
for EXD2 (Mason and Cox9 and references herein). Most striking however is that the antibody used both by 
Broderick et al. and Biehs et al.1,2 is reported at http://www.proteinatlas.org 10 as showing a distinct mitochondrial 
and possibly intermediate filament localization using immunofluorescence (IF). For this reason, we here have 
re-examined the subcellular localization and function of EXD2.
Results and Discussion
The main cellular localization of EXD2 is the mitochondrial outer membrane. We used biochem-
ical fractionation experiments and IF in combination with EXD2 knockdown or overexpression to establish its 
subcellular localization. Crude mitochondrial fractions of control and EXD2 siRNA treated U2OS cells clearly 
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identified distinct EXD2 bands, the most prominent one corresponding to the predicted full-length protein of 
approximately 70 kDa, a second weaker species of approximately 30 kDa (Fig. 1 panel a1 and a2) and several even 
fainter bands between 70 and 30 kDa. Knockdown with three individual siRNAs, instead of a mix of all three that 
we more routinely use (see M&M), showed similar knockdown of all detected bands with each siRNA (Fig. 1, 
panel a2). Since the three siRNA’s cover almost 1000 bp of the 1866 bp open reading frame, it seems likely that the 
smaller forms are either processed forms or breakdown products.
The nuclear pellets obtained during the crude mitochondrial fractionation were further purified using iodix-
anol gradient purification to remove excess mitochondria from the nuclear fractions11,12, and ran alongside 
the mitochondrial fractions (Fig. 1a1). Probing with the EXD2 antibody clearly shows that the vast majority of 
EXD2 is found in the mitochondrial fraction and not in the nuclear fraction (the same fractionation results were 
obtained using HEK293 cells, not shown). Control antibodies exclude major nuclear or mitochondrial contami-
nation of the mitochondrial and nuclear fraction, respectively. Nonetheless, a faint band for full-length EXD2 is 
observed in the nuclear fraction, but likewise mtSSB shows a faint nuclear signal, suggesting a minor mitochon-
drial contamination of this fraction. This is further corroborated by the observation that neither IF nor IF follow-
ing overexpression of the full-length protein shows evidence for nuclear EXD2 (see below, Fig. 2).
The predicted function of EXD2 combined with a mitochondrial localization suggested it might be involved 
in mtDNA metabolism. Examination of EXD2 mitochondrial localization using proteinase K (protK) protection 
showed that the protein was sensitive to digestion using intact mitochondria and outer-membrane-lysed mito-
chondria (here referred to as mitoplasts, see5), without the addition of Triton-X100 (TX100) to fully lyse mito-
chondria (Fig. 1b). In contrast, transcription factor A of mitochondria (TFAM), a well-known mtDNA binding 
protein that is essential for mtDNA maintenance13, was insensitive to externally added protK and required the 
addition of TX100 for its proteolysis. These data point to an outer-membrane localization of EXD2 and seem 
to exclude an mtDNA maintenance function. Online membrane-spanning amino-acid (AA) sequence predic-
tion tools suggest a single trans-membrane region at the N-terminus of the full-length 621 AA protein. A tight 
membrane association is supported by Na2CO3 extraction of crude mitochondria (Fig. 1c), in which case EXD2 
fractioned to the pellet together with for example the integral membrane protein COXI, whereas the majority of 
HSP60, a matrix protein, was found in the supernatant.
To further examine EXD2 localization, we used IF. Human ProteinAtlas shows a clear mitochondrial and a 
possible intermediate filament EXD2 localization with the ProteinAtlas antibody that we have used also here. 
However, since this antibody has not been validated for IF, we re-examined these findings, using siRNA mediated 
knockdown. In addition we used transient overexpression of the predicted full-length protein to examine EXD2 
localization using a validated cDNA clone. IF with the EXD2 antibody and the mitochondrial outer membrane 
marker Tomm20, showed a clear mitochondrial EXD2 signal in non-transfected U2OS cells (Fig. 2a) or primary 
fibroblasts (not shown) and in addition a signal reminiscent of intermediate filaments. This was confirmed by a 
co-incidental signal with a vimentin antibody. SiRNA mediated knockdown of EXD2 depleted the mitochondrial 
signal, however the intermediate filament signal remained, suggesting either a non-specific antibody cross reac-
tivity with intermediate filaments or an EXD2 protein isoform that is not or poorly targeted by our siRNA pool, or 
much more stable and therefore less prone to siRNA mediated depletion. Using IF, again no evidence supported 
the presence of EXD2 in the nucleus.
While this paper was under review, the mitochondrial localization of EXD2 was also reported by others14. 
However, a very crucial difference between this paper and our results concerns the localization of EXD2. While 
Silva et al. suggest EXD2 is predominantly located in the mitochondrial matrix and has a function in mitochon-
drial translation, we suggest the protein is located in the mitochondrial outer membrane. Since, the protK pro-
tection assay as presented in Fig. 1 is not all conclusive because it for example depends on a protein’s sensitivity 
to proteolysis, we further addressed this issue of contention using an in situ protein accessibility assay combined 
with IF. This assay is based on the fluorescent protease protection (FPP) assay15 and uses increasingly stringent 
lysis conditions to make the mitochondrial matrix accessible to proteins. Whereas in the case of the original FPP 
assay the sensitivity of e.g. GFP tagged proteins to added protK is tested, we here use the EXD2 antibody and 
control antibodies to test for antibody accessibility to the protein of interest. Following paraformaldehyde fixation 
and lysis with digitonin only, mitochondrial matrix proteins are inaccessible to externally added proteins such 
as antibodies and therefore not detectable using IF. If in contrast cells are lysed with TX100 following digitonin 
lysis, full antibody accessibility ensures detection of all proteins including matrix proteins. Thus, using this assay, 
we show that in the absence of TX100, the mitochondrial matrix protein MRPL12 (also used by Silva et al. in a 
co-localization assay)14 and mtDNA are not detected. However EXD2 is as easily detected as in the presence of 
TX100 (Fig. 3a). In a second series we used the outer membrane marker Tomm20 and show that it, as well as 
EXD2, but not mtDNA are readily detected in the absence of TX100 (Fig. 3b). These results thus clearly show 
that EXD2 is either outer-membrane localized or, alternatively embedded in the inner membrane with its single 
N-terminal transmembrane domain and the rest of the protein facing out, given that the commercial antibody has 
its epitope in the middle of the protein. However, careful examination of the obtained images in this experiment at 
high magnification does suggest the correct localization is in fact the outer membrane. Without TX100 lysis, both 
EXD2 and Tomm20 images show a broader mitochondrial signal than typically seen for mitochondrial matrix 
proteins, sometimes suggesting the appearance of a hollow tube. This is confirmed by the images using combined 
digitonin and TX100 lysis and detection of EXD2 and MRPL12, suggesting a narrower signal for MRPL12, with 
the EXD2 signal often clearly enveloping the MRPL12 signal (a 20 × 30 µm cellular subsection illustrates this in 
Fig. 3c). In conclusion, both our biochemical and immunofluorescence assay as well as high resolution imaging 
of EXD2 and the mitochondrial matrix protein MRPL12 consistently support an outer-membrane localization 
of EXD2.
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Figure 1. EXD2 is a mitochondrial outer-membrane associated protein. U2OS cell crude mitochondria isolated 
by differential centrifugation and pure nuclei isolated on iodixanol gradients were tested for EXD2 abundance 
in control siRNA and EXD2 siRNA treated cells (panel a1). Results show that the vast majority of EXD2, 
similar to mitochondrial marker proteins mtSSB and porin are found in the mitochondrial fraction and not in 
the nuclear fraction, in which the nuclear marker nucleophosmin is identified. SiRNA treatment confirms the 
identity of the full length (fl) ~70 kDa EXD2 protein and several lower abundant species of 30 kDa and higher 
molecular weight. Knockdown with either the combined pool of three commercial siRNAs or each individual 
siRNA show similar knockdown efficiencies in total cell lysates of U2OS cells on Western blots (panel a2). At 
the same time, several lower molecular weight EXD2 species are also identified and all appear to be equally 
sensitive to each individual siRNA suggesting they might be breakdown or processed EXD2 forms. Protease 
protection demonstrates mitochondrial EXD2 is mostly found in the mitochondrial outer-membrane (panel 
b). Mitochondria and digitonin-derived mitoplasts from HEK293 cells were treated either with Proteinase K 
(ProtK) alone or with ProtK and Triton-X100 (TX100) to lyse the inner and outer membrane. Results show that 
whereas TFAM, an mtDNA associated protein, is protected from ProtK in the absence of TX100, EXD2 is not, 
suggesting and outer-membrane localization. *Indicates a remnant signal from the probing with an antibody 
against a different mitochondrial candidate protein not relevant for this paper. A Na2CO3 extract of crude 
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EXD2 overexpression or knockdown suggest an involvement in mitochondrial morphology 
and/or dynamics. Overexpression of either a non-tagged or C-terminally tagged predicted full-length ver-
sion of the protein showed exclusive mitochondrial localization (Fig. 2b). High-level overexpression (based on 
IF signal) of both the non-tagged and tagged variant resulted in abnormal mitochondrial network morphology 
with extreme perinuclear clustering (multiple fields of view of non-tagged transiently overexpressed EXD2 are 
presented in Supplemental Fig. S1, showing the collapse of the mitochondrial network with increasing EXD2 
expression). In contrast, siRNA mediated knockdown suggested a more distributed mitochondrial network, with 
fewer cells compared to control siRNA-treated cells showing perinuclear mitochondrial abundance. These data 
might suggest a mitochondrial dynamics/morphology function of EXD2 (Fig. 4 and Supplementary Fig S1).
Mitochondrial dynamics and morphology is in part cell cycle dependent16, resulting in mosaic patterns 
of mitochondrial-cellular distribution and morphology in cultured cells. For this reason and to more clearly 
assess the EXD2 knockdown phenotypes in relation to the EXD2 antibody intermediate filament co-staining, 
we repeated knockdown experiments. In control siRNA cells, a considerable proportion showed very localized 
perinuclear clustering of the mitochondrial network, in particular in those cells that are also positive for EdU 
nuclear DNA incorporation, showing that cells are in S-phase (Fig. 4). In contrast, with the combined siRNA pool 
(EXD2si3x) we observed a more distributed mitochondrial network. This was not a variable response to EdU 
labelling as the same is observed in cells not labelled using EdU (see Supplementary Fig. S1). As also observed 
in Fig. 2, intermediate filament staining by the EXD2 antibody did not appear to be affected by the knockdown. 
In addition, vimentin antibody staining of Western blots following knockdown, did not show reduced vimentin 
levels (see Fig. 1, panel a2). Although at this point we cannot completely exclude a direct EXD2-intermediate fila-
ment interaction, our data suggest no effect of EXD2 knockdown on vimentin. In addition, overexpression of the 
full-length protein showed no evidence for intermediate filament co-localization (Fig. 2b). To summarize, EXD2 
is mainly embedded in the mitochondrial outer membrane and its overexpression or knockdown both appear to 
affect mitochondrial network morphology/dynamics.
Induction of nuclear DNA damage does not result in nuclear translocation of EXD2. Broderick 
et al.2, have stated that ‘EXD2 is recruited to chromatin in a damage dependent manner’, yet they have not shown 
this directly in their paper. Since the main localization of EXD2 is the mitochondrial outer membrane we hypoth-
esized that upon nuclear DNA damage, EXD2 might perhaps relocate to the nucleus. To address this possibility we 
treated HeLa cells (also used by Broderick et al.) with ionizing radiation (Fig. 5). Even though the DNA-damage 
γH2AX marker (e.g. Burma et al.)17 showed a strong enhancement of its nuclear signal following this treatment, 
EXD2 showed no re-distribution upon ionizing radiation, thus showing no evidence for a direct damage-foci 
localized function in nuclear DNA repair. Similarly, treatment of U2OS cells with Zeocin (a Bleomycin antibiotic 
family member) showed considerable enhancement of the γH2AX nuclear signal, while it had no effect on EXD2 
mitochondrial outer-membrane localization.
To conclude, while it has been attractive based on available data to implicate EXD2 as a new player in nuclear 
double-strand break-repair3, we here show that EXD2 is a relatively abundant outer-mitochondrial-membrane 
protein. For the various cells lines we have tested including HeLa cells there is very little if any evidence that the 
protein is also nuclear, either under normal conditions or following the induction of nuclear DNA damage. This 
is in agreement with cellular localization predictions, online antibody data from ProteinAtlas and also a recent 
paper using proximity biotinylation of mitochondrial outer membrane and ER membrane proteins18, results of 
which also support an outer mitochondrial membrane and possibly ER-mitochondrial contact-site localization 
of EXD2. Our results also contradict a mitochondrial matrix localization for EXD2, as was recently reported14 
and therefore do not support a direct role in mitochondrial translation. In contrast, EXD2 seems to play a role in 
mitochondrial dynamics, which in turn could explain the effects of its knockdown or knockout on nuclear DNA 
replication and/or repair (see e.g. Qin et al.)19, yet again illustrating the importance of mitochondrial dynamics 
in diverse cellular processes. In the future, we hope to further clarify the exact molecular function of EXD2 by 
identification of its interaction partners using proximity labelling/mass spectrometry methods and clarify a pos-
sible ER interaction.
Materials and Methods
Cell culture. HeLa, HEK293 (ATCC CRL-1573), U2OS cells (University of Helsinki, Finland) and in-house 
primary human fibroblasts were grown in Dulbecco’s modified Eagle’s medium (DMEM; Lonza BE12-604F) sup-
plemented with 10% fetal calf serum (FCS) (GE Healthcare), in a 37 °C incubator at 5% CO2. All cell lines were 
routinely tested for mycoplasma contamination and found to be negative.
RNA-interference and overexpression. For EXD2 knockdown, cells were transfected in 6 well plates (for IF) or 
10 cm cell culture dishes (for biochemical fractionation experiments) with a mixture of three StealthTM siRNA 
duplex oligonucleotides (EXD2 HSS124153, HSS124155 and HSS182946 Invitrogen), at a concentration of 10 nM 
each, using LipofectamineTM2000. Alternatively the individual siRNAs were used at a concentration of 30 nM. As 
controls we used StealthTM Universal negative controls at the same concentrations.
mitochondria from HEK293 cells (panel c) shows that similar to cytochrome c oxidase subunit I (an integral 
membrane protein), full length EXD2 is found predominantly in the pellet (membrane) fraction, whereas 
the majority of HSP60 is found in the supernatant (non-membrane) fraction. For each panel (except panel b) 
cropped images show the results of incubations with subsequent antibodies on the same blots, indicated by 
dividing lines (see Supplementary info for full blot images).
www.nature.com/scientificreports/
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A commercial cDNA clone for the predicted full-length cDNA for EXD2 and containing a Myc-DDK (FLAG) 
tag was acquired from Origene (Catalogue nr. RC231340) and recloned either with or without tag in a gateway 
customized pcDNA5/FRT/TO (Invitrogen) plasmid (kind gift of Dr. LGJ Nijtmans) using the Gateway recom-
bination system. Inserts were fully sequenced to verify the wild-type sequence. Plasmids were used in transient 
transfections using TransIT-LT1 transfection reagent (Mirus), using manufacturer’s instructions.
Mitochondrial isolation and iodixanol gradient purification of nuclei. U2OS cells were collected and resuspended 
in hypotonic buffer (4 mM Tris-HCl, pH 7.8, 2.5 mM NaCl, 0.5 mM MgCl2 including protease inhibitors (Roche 
Figure 2. Knockdown or overexpression in U2OS cells of full-length EXD2 confirms the mitochondrial 
localization of EXD2. ProteinAtlas describes their EXD2 antibody, which we have used throughout this study, as 
having a mitochondrial and possible intermediate filament localization. To test the localization and the validity 
of their antibody we tested the EXD2 antibody, together with an antibody against the outer-membrane protein 
Tomm20 and an antibody against the intermediate filament protein vimentin (Vim) using immunofluorescence 
following transfection with either a pool of non-targeting control siRNAs or a pool of three EXD2 Stealth 
siRNAs (panel a). Co-staining in control siRNA cells with Tomm20 and vimentin shows co-localization of the 
EXD2 signal both with mitochondrial and intermediate filament signals. EXD2 siRNA treatment shows that 
while the EXD2 mitochondrial signal is no longer observed, the intermediate filament signal remains suggesting 
that this signal is either non-specific or that the siRNA pool used does not affect intermediate filament 
associated EXD2. Transient overexpression of the predicted full length protein, either w/o a tag or with a 
C-terminal combined Myc/FLAG tag shows an exclusive mitochondrial localization of the protein as illustrated 
by Tomm20 co-staining, while higher level overexpression results in mitochondrial perinuclear clustering 
(panel b). With very high overexpression, the whole mitochondrial network collapsed in one large perinuclear 
cluster that had lost any typical mitochondrial network-like structure (Supplementary Fig. S1). Overexpressed 
full length EXD2 showed no evidence of either nuclear or intermediate filament localization. Please note that 
for this Figure images have been selected deliberately to best illustrate the mitochondrial localization of EXD2. 
Image views have thus been chosen showing cells with a clear and extended mitochondrial network, while 
trying to avoid cells with a condensed/collapsed mitochondrial network.
www.nature.com/scientificreports/
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Figure 3. EXD2 is accessible to added antibody in immunofluorescence without mitochondrial lysis. 
Immunofluorescent detection following paraformaldehyde fixation requires mitochondrial lysis using 
for example Triton X100. In the absence of this lysis step mitochondrial matrix proteins and for example 
mtDNA are not detectable. Thus (panel a) results shows that in the absence of TX100 lysis, EXD2 is 
detected while neither MRPL12 nor mtDNA are detected by IF. With TX100 lysis, all three are detected. 
A similar experiment (panel b) shows that both Tomm20 and EXD2, but not mtDNA are detected in the 
absence of TX100 lysis. A high resolution 20 × 30 µM subsection of a cell using the EXD2 and MRPL12 
antibodies illustrates that the EXD2 signal is often enveloping the MRPL12 signal (panel c: some examples 
are indicated by a white arrow in the merged image), further illustrating EXD2 its outer-membrane 
localization.
www.nature.com/scientificreports/
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Molecular Biochemicals)) allowed to swell for 10 min and disrupted with 20–25 strokes with a Dounce homogenizer 
on ice. The suspension was re-isotonised with 0,1 volume of 400 mM Tris-HCl, 250 mM NaCl and 50 mM MgCl2. 
Nuclei and cell debris were first pelleted by centrifugation at 1 200 g for 5 min at 4 °C. The low speed centrifugation was 
repeated once and crude mitochondria were then pelleted from the cytosol by centrifugation at 13 000 g for 10 min at 
4 °C. The low speed nuclear pellet was further subjected to iodixanol gradient purification as previously described11 and 
pure nuclei were extracted in 20 mM Tris/HCl (pH 7.9), 25% glycerol, 0.42 M NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, 
0.1 mM PMSF and 0.5 mM DTT20. Na2CO3 extraction of crude mitochondria was done as previously described5.
Protein analyses. Were carried out by Western blotting after separation by SDS-PAGE. Proteins were trans-
ferred from the gel onto a nitrocellulose membrane, which was probed with antibodies against proteins of interest 
and HRP-conjugated secondary antibodies followed by ECL detection. ECL reactions were visualized with a 
ChemiDoc instrument (Biorad). Antibodies used for Western blot detection were mtSSB (Sigma, HPA002866), 
EXD2 (Sigma, HPA005848), vimentin (Abcam Ab24525), nucleophosmin (Invitrogen, 32–5200), Porin 
(Invitrogen, A31855), TFAM (kind gift of Dr. R. Wiesner), COXI (Invitrogen), HSP60 (Abcam, Ab46798).
Immunofluorescence. For immunofluorescent detection cells were grown on coverslips in 6 well plates. Cells 
were fixed using 3.3% paraformaldehyde (PFA) in cell culture medium for 15–25 min, washed 3x in PBS and per-
meabilized for 15 min with 0.5% Triton X100 in PBS/10% FCS. Primary and secondary antibodies were incubated at 
the following concentrations in PBS/10%FCS for 1 h: EXD2 rabbit polyclonal (Sigma, HPA005848), 1:200; Tomm20 
mouse monoclonal (Santa Cruz, sc17764), 1:100; MRPL12 mouse monoclonal (Abcam, Ab58334), 1:200; vimentin 
chicken polyclonal (Abcam, Ab24525), 1:200. Secondary goat-anti-rabbit, goat-anti-mouse and goat anti-chicken 
IgG were AlexaFluor 488, 568, and 647 (Invitrogen) labelled and used in various combinations at a 1:1000 dilution. 
5-ethynyl-2′-deoxyuridine (EdU) labelling and detection (Invitrogen), to identify nuclear DNA synthesis, was done 
as previously described5 with in this case a short 30 min labelling period. For the immunofluorescent antibody 
accessibility assay, cells were treated with 100 µM digitonin in PBS for 7 min at RT following PFA fixation. Cells 
were subsequently washed 3x with PBS and either or not further permeabilized with TX100 followed by antibody 
incubations as above. For U2OS ZeocinTM (Invivogen) treatment, Zeocin was added at a final concentration of 
250 µg/ml and incubated for 1 hr. Cells were washed once with cell culture medium and allowed to recover for an 
additional hour in cell culture medium. Slides were then processed for immunofluorescent detection with EXD2 
and gamma-H2AX antibodies (see below: Nuclear DNA damage and repair induction by irradiation). Slides were 
mounted using ProLong® Gold antifade with DAPI (Invitrogen). Image acquisition used the Zeiss apotome system 
on an axio-observer Z.1 with Colibri led illumination and appropriate emission filters. In all cases in which controls 
are compared with experimental manipulation of cells (for example using siRNA), images have been acquisitioned 
with identical illumination and exposure settings and processed identically. Where needed, images were further 
processed using ImageJ or Photoshop to adjust brightness/contrast and size/resolution.
Nuclear DNA damage and repair induction by irradiation. HeLa cells were grown overnight on 
coverslips in 6 well plates and X-irradiated with doses of 0 or 13 Gy with an X-RAD 320 biological irradiator 
(Precision X-ray, Inc., PAVIRMA platform, Clermont-Ferrand, France). After a 30 min recovery at 37 °C, cells 
were washed with PBS, fixed with 3.7% formaldehyde in PBS at 37 °C for 15 min, washed 3x with PBS-0.1% Tween 
Figure 4. SiRNA mediated knockdown of EXD2 in U2OS cells results in a more widely spread mitochondrial 
network. In order to understand possible effects of EXD2 knockdown on mitochondrial network behaviour we 
labelled cells with EdU to identify cells in S-phase, in order to get a handle on mosaicism resulting from cell-
cycle mediated effects on mitochondrial network dynamics (see main text). For this, cells were incubated for 
30 min with EdU following transfection and 48–60 hrs incubation with either a pool of non-targeting control 
siRNAs (Csi) or a pool of three EXD2 stealth siRNAs (EXD2si3x). Following labelling for EdU incorporation 
(green, gr), cells were further labelled with antibodies for Tomm20 (red, r) and EXD2 (white). Control siRNA 
treated cells show frequent and strong perinuclear clustering of the mitochondrial network in particular in EdU 
positive cells. In contrast, the EXD2si3x typically show a more distributed and sometimes more hyperfused 
network. Two fields of view are shown for each condition.
www.nature.com/scientificreports/
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(PBST), permeabilized with PBS-0.5% Triton 100× at RT for 10 min, washed 3 times with PBST and incubated 
with a blocking solution (1% BSA, 22.52 mg/mL glycine in PBST) at RT for 30 min. For visualization of EXD2 
and gamma-H2AX, coverslips were then incubated with anti-EXD2 antibody (1:200 in PBS, Sigma HPA005848) 
and anti-gamma-H2AX antibody (1:200 in PBS, Merck Millipore 05-636-I) at RT for 1 hr30. Unbound antibod-
ies were removed with 3 washes with PBST. Coverslips were incubated at RT for 1hr with secondary antibodies, 
anti-rabbit IgG conjugated to Alexa Fluor 555 (1:1000 in PBS) and anti-mouse IgG conjugated to Alexa Fluor 488 
(1:1000 in PBS, Molecular Probes A21151). Cells were washed 3x with PBST and DNA was counterstained with 
DAPI. A final wash was performed with PBS. Coverslips were mounted using 10ul PBS/Glycerol (50/50, v/v) and 
observed using a Leica MMAF Imaging NX microscope powered by Metamorph.
Data availability. The data generated during and/or analyzed during the current study are available from the 
corresponding author on reasonable request.
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